RecruitingNCT05013944
AnovaOS Network Powered Patient Registry
Sponsor
Anova Enterprises, Inc
Enrollment
100,000 participants
Start Date
Sep 1, 2021
Study Type
OBSERVATIONAL
Conditions
NeoplasmsDiseases of the Circulatory SystemInfectious DiseaseDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural DisordersDiseases of the Nervous SystemDiseases of the Eye and AdnexaDiseases of the Ear and Mastoid ProcessDiseases of the Respiratory SystemDiseases of the Digestive SystemDiseases of the Skin and Subcutaneous TissueDiseases of the Musculoskeletal System and Connective TissueDiseases of the Genitourinary SystemPregnancy, Childbirth and the PuerperiumCertain Conditions Originating in the Perinatal PeriodCongenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere ClassifiedInjury, Poisoning and Certain Other Consequences of External CausesExternal Causes of Morbidity and MortalityFactors Influencing Health Status and Contact With Health Services
Summary
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- years old or older;
- Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
- Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
- Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
- Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
- Anticipated additional follow up with the registry once per year.
- Subjects who are unable to understand the protocol or unable to provide legally effective informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05013944
Related Trials
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
NCT0678563624 locations
An International Observational Study of Adults With Acute Infection
NCT0706940047 locations
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
NCT072763734 locations
Sample Collection and Tracking for the Developmental Therapeutics Clinic
NCT032695781 location
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
NCT033661161 location